AROG Pharmaceuticals is a private, clinical-stage biopharmaceutical company that has leveraged its platform of benzimidazole derivatives to develop a robust drug pipeline of orally available, potent, and selective small molecule type I kinase inhibit...Show all
Company (Alive / Active)
Phone:
5420 LBJ Freeway
Suite 410
Dallas, 75240
Texas, United States
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Method of inhibiting mutant c-kit | Feb 22, 2019 | Nov 17, 2020 | Patent |
Method of inhibiting constitutively active phosphorylated flt3 kinase | Sep 26, 2017 | Sep 22, 2020 | Patent |
Method of inhibiting mutant c-kit | Jan 04, 2018 | Apr 09, 2019 | Patent |
Crenolanib for treating flt3 mutated proliferative disorders | Sep 26, 2017 | Feb 26, 2019 | Patent |
Method of inhibiting mutant c-kit | Sep 02, 2016 | Feb 13, 2018 | Patent |